J & J and other experimental, rushed to market flu/covid jabs were designed to irreparably harm health on the phony pretext of providing protection not gotten.
Drs. Michael Palmer, Sucharit Bhakdi and Wolfgang Wodarg (PBW below) explained the lack of safety and efficacy of J & J’s so-called “vaccine.”
The term is misused for Pharma kill shots across the board.
In 2019, the US definition of biological products was changed to label hazardous to health, DNA altering jabs, “vaccines.”
J & J’s entry into the flu/covid sweepstakes to cash in on a bonanza of profiteering is “a (toxic) form of gene therapy,” PBW explained.
It’s “not a traditional vaccine.”
Falsely claiming otherwise “mislead(s) and promotes unjustified expectations in the public’s mind of a protective effect with low risk” that J & J jabs don’t provide.
The firm’s “gene delivery system…risk(s) delayed, grave disease.”
Introducing “foreign DNA…into the human genome…creates the potential for dangerous (health-destroying) side effects” — while providing nothing beneficial.
“(I)rreversibly alter(ing) human cells” causes irreparable harm.
J & J kill shots are “replication-deficient.”
According to the National Center for Biotechnology Information,“replication-defective mutant viruses are defective for one or more functions that are essential for viral genome replication or synthesis and assembly of viral particles.”
J & J kill shots can “establish an infection in (jabbed) persons (that) potentially (can) also be transmitted and spread in the population,” PBW explained.
Animal trials were “limited.”
Other “non-clinical data” were insufficient to grant emergency use authorization.
PBW “maintain that in accepting this evidence,” Western and other regulatory agencies “acted negligently…”
“J & J was absolved of its responsibility to prove that its product is safe simply by using the semantic trick of calling this experimental gene therapy a ‘vaccine.’ ”
“The safety testing requirements that really should have been applied in this case are those for gene therapy products, which require some very involved long-term follow-up studies” were not conducted.
Approval of J & J jabs “for use in humans without prior safety pharmacology tests to address these pathogenic mechanisms (was) irresponsible.”
“J & J also performed no preclinical studies on pharmacodynamic drug interactions, which means that there are no available data concerning the behavior of (its jabs) in recipients who show physiological changes due to diseases, genetic mutations, aging or the influence of other drugs.”
J & J, Pfizer, Moderna and AstraZeneca flu/covid jabs pose a high risk of generating what’s called antibody-dependent enhancement (ADE).
It enables a virus to enter cells and worsen disease.
Instead of protecting against pathogens, antibodies instead let foreign particles enter the body, weaken immunity, worsen disease, and risk contraction of other serious illnesses.
PBW stressed that “(u)ntil and unless proof positive to the opposite is adduced, we must assume that the current crop of (flu/covid jabs), including…J & J(’s), may cause ADE.”
‘In this context, we note that J & J (jabs) showed an almost threefold increased risk of (flu/covid) infection, relative to” being jab-free.
“ADE seems to be the most straightforward explanation for this observation from the real world.”
“The real-world efficacy of Johnson & Johnson (jabs) is negative.”
Their “true efficacy is not 95% (as falsely claimed), but rather close to 0%.”
Kill shots across the board irreparably harm health and don’t protect.
Flu/covid mass-jabbing is “unnecessary,” PBW stressed.
“The vast majority of persons infected with (flu/covid) recover” fully.
“According to world-leading epidemiologist John Ioannidis, the infection fatality rate of (flu/covid) is on the order of 0.1% to 0.2% across all age groups, with a very strong bias towards old people, particularly those with co-morbidities.”
Sucharit Bhakdi MD is Professor Emeritus of Medical Microbiology and Immunology and Former Chair, Institute of Medical Microbiology and Hygiene, Johannes Gutenberg University of Mainz.
Michael Palmer MD is Associate Professor of biochemistry in the Department of Chemistry at the University of Waterloo, Ontario, Canada.
Wolfgang Wodarg MD is a specialist in pulmonary and bronchial internal medicine, hygiene and environmental medicine, epidemiology, and public health.
He formerly headed the Health Committee of the Parliamentary Assembly of the Council of Europe.